Glaukos

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.

CEO

Thomas William Burns

CEOThomas William Burns

Employees

907

Employees907

Headquarters

Aliso Viejo, California

HeadquartersAliso Viejo, California

Founded

1998

Founded1998

Employees

907

Employees907

GKOS Key Statistics

Market cap

4.89B

Market cap4.89B

Price-Earnings ratio

-34.21

Price-Earnings ratio-34.21

Dividend yield

—

Dividend yield—

Average volume

482.89K

Average volume482.89K

High today

$97.42

High today$97.42

Low today

$95.67

Low today$95.67

Open price

$95.67

Open price$95.67

Volume

59.95K

Volume59.95K

52 Week high

$102.33

52 Week high$102.33

52 Week low

$45.38

52 Week low$45.38

GKOS News

Yahoo Finance 3d

Glaukos Announces the Release of its 2023 Sustainability Report - Yahoo Finance

ALISO VIEJO, Calif., April 16, 2024--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on n...

Analyst ratings

71%

of 14 ratings

Buy

71.4%

Hold

28.6%

Sell